Details for Patent: 8,318,802
✉ Email this page to a colleague
Which drugs does patent 8,318,802 protect, and when does it expire?
Patent 8,318,802 protects VELETRI and is included in one NDA.
This patent has nineteen patent family members in fifteen countries.
Summary for Patent: 8,318,802
Title: | Epoprostenol formulation and method of making thereof |
Abstract: | This invention relates to a stable epoprostenol composition that can be combined with commercially available IV fluids and can be administered in its reconstituted and/or diluted form under ambient conditions of about 15-30.degree. C. for greater than 24 hours. The composition preferably contains (a) epoprostenol or a salt thereof; (b) a alkalinization agent; and (c) a base, such that when reconstituted or in solution, the solution has a pH>11. Methods for making the lyophilized composition are also disclosed. |
Inventor(s): | Palepu; Naglesh R. (Southampton, PA) |
Assignee: | Actelion Pharmaceuticals Ltd. (Altschwil, CH) |
Application Number: | 12/278,061 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,318,802 |
Patent Claim Types: see list of patent claims | Composition; Formulation; |
Drugs Protected by US Patent 8,318,802
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Actelion | VELETRI | epoprostenol sodium | INJECTABLE;INJECTION | 022260-002 | Jun 28, 2012 | AP2 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Actelion | VELETRI | epoprostenol sodium | INJECTABLE;INJECTION | 022260-001 | Jun 27, 2008 | AP2 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,318,802
PCT Information | |||
PCT Filed | February 02, 2007 | PCT Application Number: | PCT/US2007/002948 |
PCT Publication Date: | August 16, 2007 | PCT Publication Number: | WO2007/092343 |
International Family Members for US Patent 8,318,802
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Brazil | PI0707488 | ⤷ Try a Trial | |||
Canada | 2641393 | ⤷ Try a Trial | |||
Canada | 2868998 | ⤷ Try a Trial | |||
China | 101410119 | ⤷ Try a Trial | |||
Cyprus | 1117128 | ⤷ Try a Trial | |||
Denmark | 1993557 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |